A review of the latest research on Mpro targeting SARS-COV inhibitors

Literature Information

Publication Date 2021-04-14
DOI 10.1039/D1MD00066G
Impact Factor 0
Authors

Huihui Yang


View Original

Abstract

Since the outbreak of COVID-19, the pandemic caused by SARS-CoV-2 infection is still spreading at an alarming rate and has caused huge loss of life and economic damage worldwide. Although more than one year has passed, effective treatments for COVID-19 and other pathogenic coronaviruses have not yet been developed. Therefore, the development of SARS-CoV-2 inhibitors is an urgent priority. Given that the Mpro sequences of SARS-CoV-2 and SARS-CoV-1 are 100% identical in the catalytic domain for protein cleavage, the viral main protease (Mpro) is one of the most extensive drug targets in all the drug targets being investigated for SARS-CoV-2. To provide scientific researchers with timely anti-SARS-CoV drug development information for Mpro, we focus on the past and current drug design and development strategies for MPro in this review. We believe that this review will provide meaningful guidance for the design and development of innovative drugs against COVID-19 and other pathogenic coronaviruses in the future.

Related Literature

Biosensor surface functionalization by a simple photochemical immobilization of antibodies: experimental characterization by mass spectrometry and surface enhanced Raman spectroscopy

Bartolomeo Della Ventura, Martina Banchelli, Riccardo Funari, Anna Illiano, Marella De Angelis, Paola Taroni, Angela Amoresano, Paolo Matteini, Raffaele Velotta

2019-10-10 Paper

DOI: 10.1039/C9AN00443B

Front cover

Cover

DOI: 10.1039/C6AN90040B

Tunicamycin induced endoplasmic reticulum changes in endothelial cells investigated in vitro by confocal Raman imaging

Nikola Mielniczek, Magdalena Jarosz, Joanna Denbigh, Renata Budzynska

2019-08-27 Paper

DOI: 10.1039/C9AN01456J

Investigating the effect of Ag nanocube polydispersity on gap-mode SERS enhancement factors

Tyler J. Dill, Matthew J. Rozin, Eric R. Brown, Stephen Palani, Andrea R. Tao

2016-04-29 Paper

DOI: 10.1039/C6AN00212A

Real-time monitoring of calcification process by Sporosarcina pasteurii biofilm

Dustin Harris, Jyothir Ganesh Ummadi, Andrew R. Thurber, Yvan Allau, Circe Verba, Frederick Colwell, Marta E. Torres, Dipankar Koley

2016-02-29 Paper

DOI: 10.1039/C6AN00007J

Voltammetric detection of glutathione: an adsorptive stripping voltammetry approach

Madalena C. C. Areias, Kenichi Shimizu, Richard G. Compton

2016-04-01 Paper

DOI: 10.1039/C6AN00550K

Front cover

Cover

DOI: 10.1039/C6AN90044E

Recent advances in inorganic materials for LDI-MS analysis of small molecules

C. Y. Shi, C. H. Deng

2016-03-18 Minireview

DOI: 10.1039/C6AN00220J

Epigenetic subtyping of white blood cells using a thermoplastic elastomer-based microfluidic emulsification device for multiplexed, methylation-specific digital droplet PCR

Lidija Malic, Jamal Daoud, Matthias Geissler, Alex Boutin, Ljuboje Lukic, Mojra Janta, Abdelrahman Elmanzalawy, Teodor Veres

2019-10-15 Paper

DOI: 10.1039/C9AN01316D

You might also like

Compound Q&A

What are the main uses of (3alpha,5alpha)-3-Hydroxypregnane-11,20-dione (CAS: 23930-19-0)?

(3alpha,5alpha)-3-Hydroxypregnane-11,20-dione is primarily used in the pharmaceu...

23930-19-0(3alpha,5alpha)-3-Hy...
Compound Q&A

What is the market or research trend for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4)?

The market for 4-Amino-6-chloro-2-pyridinecarboxylic acid (CAS: 546141-56-4) is ...

546141-56-44-Amino-6-chloro-2-p...
Compound Q&A

Are there alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in synthesis?

Alternatives to (2-Benzoylethyl)trimethylammonium chloride (CAS: 24472-88-6) in ...

24472-88-6(2-Benzoylethyl)trim...
Compound Q&A

Is N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) safe?

N-[4-Nitro-3-(trifluoromethyl)phenyl]acetamide (CAS: 393-12-4) is generally safe...

393-12-4N-[4-Nitro-3-(triflu...
Compound Q&A

Are there alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-14-5) in synthesis?

There are alternatives to N,N'-Bis(3-aminopropyl)-1,3-propanediamine (CAS: 4605-...

4605-14-5N,N'-Bis(3-aminoprop...
Compound Q&A

What precautions should be taken when handling Aluminium trihexadecanoate (CAS: 555-35-1)?

When handling Aluminium trihexadecanoate, it is important to use appropriate per...

555-35-1Aluminium trihexadec...
Compound Q&A

What is (1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid (CAS: 52188-11-1)?

(1,1-Dioxido-3-oxo-1,2-benzothiazol-2(3H)-yl)acetic acid is a chemical compound ...

52188-11-1(1,1-Dioxido-3-oxo-1...
Compound Q&A

Are there alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) in synthesis?

Several alternatives to 5,5-dimethyloxolan-2-one (CAS: 3123-97-5) can be used in...

3123-97-55,5-dimethyloxolan-2...

Source Journal

RSC Medicinal Chemistry

RSC Medicinal Chemistry
CiteScore: 0
Self-citation Rate: 0%
Articles per Year: 0

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.